Teva Pharmaceutical Industries Ltd (TEVA)
13.01
0.00 (0.00%)
USD |
NYSE |
Apr 24, 16:00
13.00
-0.01
(-0.08%)
Pre-Market: 07:02
Teva Pharmaceutical Industries Revenue (Annual): 15.84B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.84B |
| December 31, 2022 | 14.92B |
| December 31, 2021 | 15.88B |
| December 31, 2020 | 16.66B |
| December 31, 2019 | 16.89B |
| December 31, 2018 | 18.27B |
| December 31, 2017 | 21.85B |
| December 31, 2016 | 21.90B |
| December 31, 2015 | 19.65B |
| December 31, 2014 | 20.27B |
| December 31, 2013 | 20.31B |
| December 31, 2012 | 20.32B |
| December 31, 2011 | 18.31B |
| December 31, 2010 | 16.12B |
| December 31, 2009 | 13.90B |
| December 31, 2008 | 11.08B |
| December 31, 2007 | 9.408B |
| December 31, 2006 | 8.408B |
| December 31, 2005 | 5.25B |
| Date | Value |
|---|---|
| December 31, 2004 | 4.799B |
| December 31, 2003 | 3.276B |
| December 31, 2002 | 2.519B |
| December 31, 2001 | 2.077B |
| December 31, 2000 | 1.750B |
| December 31, 1999 | 1.282B |
| December 31, 1998 | 1.116B |
| December 31, 1997 | 1.117B |
| December 31, 1996 | 953.80M |
| December 31, 1995 | 811.30M |
| December 31, 1994 | 728.30M |
| December 31, 1993 | 502.00M |
| December 31, 1992 | 396.30M |
| December 31, 1991 | 327.10M |
| December 31, 1990 | 329.00M |
| December 31, 1989 | 281.10M |
| December 31, 1988 | 211.10M |
| March 31, 1987 | 139.60M |
| March 31, 1986 | 91.20M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
14.92B
Minimum
2022
16.89B
Maximum
2019
16.04B
Average
15.88B
Median
2021
Revenue (Annual) Benchmarks
| Viatris Inc | 15.43B |
| Alvotech | 91.43M |
| Johnson & Johnson | 85.16B |
| AbbVie Inc | 54.32B |
| Novartis AG | 46.66B |